Thompson Siegel & Walmsley LLC Ani Pharmaceuticals Inc Transaction History

Thompson Siegel & Walmsley LLC

$6.71 Billion
Q3 2024

A detailed history of Thompson Siegel & Walmsley LLC transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Thompson Siegel & Walmsley LLC holds 230,159 shares of ANIP stock, worth $13.5 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

230,159

Previous 195,743 17.58%

Holding current value

$13.5 Million

Previous $12.5 Million 10.16%

% of portfolio

0.2%

Previous 0.2%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$54.33 - $65.72 $1.87 Million - $2.26 Million	34,416 Added 17.58%	230,159 $13.7 Million
Q2 2024 Aug 08, 2024	BUY	$58.53 - $68.82 $174,770 - $205,496	2,986 Added 1.55%	195,743 $12.5 Million
Q1 2024 May 09, 2024	SELL	$54.2 - $69.69 $1.09 Million - $1.4 Million	-20,154 Reduced 9.47%	192,757 $13.3 Million
Q4 2023 Feb 07, 2024	SELL	$48.72 - $65.43 $769,581 - $1.03 Million	-15,796 Reduced 6.91%	212,911 $11.7 Million
Q3 2023 Nov 08, 2023	SELL	$50.28 - $64.61 $6.72 Million - $8.63 Million	-133,584 Reduced 36.87%	228,707 $13.3 Million
Q2 2023 Aug 10, 2023	SELL	$37.29 - $53.83 $1.17 Million - $1.7 Million	-31,498 Reduced 8.0%	362,291 $19.5 Million
Q1 2023 May 11, 2023	SELL	$37.61 - $45.72 $808,276 - $982,568	-21,491 Reduced 5.18%	393,789 $15.6 Million
Q4 2022 Feb 10, 2023	SELL	$31.9 - $41.95 $21,755 - $28,609	-682 Reduced 0.16%	415,280 $16.7 Million
Q3 2022 Dec 15, 2022	BUY	$29.83 - $38.01 $12.4 Million - $15.8 Million	415,962 New	415,962 $13.4 Million
Q2 2022 Jul 22, 2022	BUY	$23.09 - $33.46 $272,138 - $394,359	11,786 Added 2.78%	435,873 $12.9 Million
Q1 2022 Apr 26, 2022	BUY	$26.91 - $47.15 $3.89 Million - $6.81 Million	144,533 Added 51.7%	424,087 $11.9 Million
Q4 2021 Feb 09, 2022	SELL	$32.97 - $56.85 $5.64 Million - $9.72 Million	-170,950 Reduced 37.95%	279,554 $12.9 Million
Q3 2021 Nov 05, 2021	BUY	$26.48 - $35.99 $1.85 Million - $2.52 Million	70,030 Added 18.41%	450,504 $14.8 Million
Q2 2021 Aug 09, 2021	BUY	$31.86 - $38.6 $1.65 Million - $2 Million	51,935 Added 15.81%	380,474 $13.3 Million
Q1 2021 May 07, 2021	SELL	$28.4 - $36.14 $121,211 - $154,245	-4,268 Reduced 1.28%	328,539 $11.9 Million
Q4 2020 Feb 08, 2021	SELL	$23.69 - $31.47 $100,232 - $133,149	-4,231 Reduced 1.26%	332,807 $9.67 Million
Q3 2020 Nov 12, 2020	BUY	$26.38 - $33.1 $1.01 Million - $1.26 Million	38,104 Added 12.75%	337,038 $9.51 Million
Q2 2020 Aug 11, 2020	BUY	$29.93 - $50.1 $8.83 Million - $14.8 Million	294,992 Added 7483.31%	298,934 $9.67 Million
Q1 2020 May 12, 2020	BUY	$30.35 - $67.14 $119,639 - $264,665	3,942 New	3,942 $161,000

Others Institutions Holding ANIP

# of Institutions

213

Shares Held

18.6M

Call Options Held

11.7K

Put Options Held

10.5K

View Full List

About ANI PHARMACEUTICALS INC

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $1.02B
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

More about ANIP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Thompson Siegel & Walmsley LLC, based on Form 13F filings with the SEC.

News

Stay updated on Thompson Siegel & Walmsley LLC with notifications on news.

Account

Thompson Siegel & Walmsley LLC Ani Pharmaceuticals Inc Transaction History